Oleamide for Health & Longevity - Quick Reference Sheet

Oleamide for Health & Longevity

Created on 07/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Oleamide is a fat-based molecule the body makes, best known as one of the brain's own sleep signals. Animal studies reliably show sleep promotion plus hints of calmer mood, brain protection, and memory support, but only one small human trial exists and long-term safety is unknown. Inexpensive and available; promise remains early and uncertain. (Full Review)

Protocol

Dose
100 mg
One capsule; stated range 1–2 times daily
Timing
30–60 min before bed
Evening/pre-sleep, single nightly dose
With food
Take with a meal
Aligns with fat-based absorption
Time to effect
Sleep
Same night
Taken 30–60 min before bed
Memory & cognition
Over weeks
Measured after 12 weeks in the human trial

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Children
  • Prescription sedative use or sedative-misuse history
  • Before driving or operating machinery
Key Interactions
  • OTC sedating antihistamines & "PM" products (diphenhydramine, doxylamine)
  • Sedating supplements (melatonin, valerian, kava, magnesium, L-theanine, phenibut, GABA)
  • Cannabis & cannabinoids (THC, high-dose CBD)
  • Blood-pressure-lowering agents (antihypertensives, nitrate/beetroot, arginine)
  • CYP-sensitive drugs (warfarin, phenytoin, theophylline)

Risk & Side Effects

  • High: [risks_high]
  • Medium: [risks_medium]
  • Low: Daytime drowsiness & sedation; additive sedation with central depressants
  • Speculative: Blood pressure lowering / hypotension; pro-inflammatory immune shifts; drug-metabolizing enzyme modulation; contaminant & purity concerns; unknown long-term & reproductive safety

Monitoring

Marker Target Why
ALT / AST ALT ~10–26 U/L; AST ~10–26 U/L Screen liver health given oleamide's modulation of liver enzymes in animals
Blood pressure ~110–125 / 70–80 mmHg Context for oleamide's vasodilator/blood-pressure-lowering signal
Fasting glucose / HbA1c Glucose ~75–85 mg/dL; HbA1c <5.4% Optional metabolic context given rodent metabolic effects
hs-CRP <1.0 mg/L Optional check given oleamide's conflicting immune effects

Cadence: Subjective review at 4 weeks and again at 8–12 weeks; safety labs only every 6–12 months or if a specific concern arises

Qualitative Assessment

  • Time to fall asleep and number of night-time awakenings
  • Subjective sleep depth and morning refreshment
  • Presence or absence of next-day grogginess or drowsiness
  • Daytime mood, calm, and stress resilience
  • Memory and cognitive clarity over weeks of use